A National Survey of United States-Based Endocrinologists Who Prescribe Gender-Affirming Hormone Therapy

• Published in: Endocrine practice Vol. 29; no. 6; p. 465
• Main Authors: Bisno, Daniel I, Lubitz, Sara, Marshall, Ian, Cohen, David A
• Format: Journal Article
• Language: English
• Published: United States 01.06.2023
• Subjects: Adult; Endocrinologists; Gender Dysphoria - drug therapy; Gender Identity; Hormones; Humans; Transgender Persons - psychology; United States; United States; LGBTQ; transgender; gender-affirming hormone therapy
• ISSN: 1530-891X
• DOI: 10.1016/j.eprac.2023.03.003

The World Professional Association for Transgender Health Standards of Care Version 7 recommended that before initiating gender-affirming hormone therapy (GAHT), patients should seek a psychosocial evaluation from a mental health professional documenting a diagnosis of persistent gender dysphoria. The Endocrine Society published guidelines in 2017 recommending against an obligatory psychosocial evaluation, which was affirmed in the recently published World Professional Association for Transgender Health Standards of Care Version 8 from 2022. Little is known about how endocrinologists ensure appropriate psychosocial assessment for their patients. This study assessed the protocols and characteristics of U.S.-based adult endocrinology clinics that prescribe GAHT. An anonymous electronic survey sent to members of a professional organization and the "Endocrinologists" Facebook group was responded by 91 practicing board-certified adult endocrinologists who prescribe GAHT. Thirty-one states were represented by the respondents. Overall, 83.1% of GAHT-prescribing endocrinologists reported accepting Medicaid. They reported working in university practices (28.4%), community practices (22.7%), private practices (27.3%), and other practice settings (21.6%). Overall, 42.9% of the respondents reported that their practice required documentation of a psychosocial evaluation from a mental health professional before initiating GAHT. Endocrinologists who prescribe GAHT are divided about requiring a baseline psychosocial evaluation before prescribing GAHT. Further work is needed to understand the impact of psychosocial assessment on patient care and facilitate the uptake of new guidelines into clinical practice.